A Broader View of ARDS

  • B. Ricou
Part of the Yearbook of Intensive Care and Emergency Medicine book series (YEARBOOK, volume 1996)

Abstract

Since the adult respiratory distress syndrome (ARDS) was first defined by Ashbaugh et al in 1967 [1], there has been increasing evidence that this syndrome encompasses a number of very different diseases. Diverse clinical circumstances can induce acute lung injury (ALI) [2] but no element common to all these circumstances has been found. Why does severe trauma induce ARDS? Why does septic shock induce the “same” lung injury? What are the common mediators which contribute to the occurrence of ALI?

Keywords

Surfactant Glutathione Superoxide Pancreatitis Interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ashbaush DG, Bigelow DB, Petty TL (1967) Acute respiratory distress in adults. Lancet 2: 319–323CrossRefGoogle Scholar
  2. 2.
    Fowler AA, Hamman RF, Good JT, et al (1983) Adult respiratory distress syndrome: Risk with common predispositions. Ann Intern Med 98: 593–597Google Scholar
  3. 3.
    Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA (1991) Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am Rev Respir Dis 144: 268–271PubMedCrossRefGoogle Scholar
  4. 4.
    Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM (1992) High broncho-alveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 145: 1016–1022PubMedCrossRefGoogle Scholar
  5. 5.
    Martin C, Papazian L, Payan MJ, Saux P, Gouin F (1995) Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. Chest 107: 196–200PubMedCrossRefGoogle Scholar
  6. 6.
    Dreyfuss D, Soler P, Saumon G (1995) Mechanical ventilation-induced pulmonary edema: Interaction with previous lung alterations. Am J Respir Crit Care Med 151: 1568–1575PubMedGoogle Scholar
  7. 7.
    Marks JD, Berman Marks C, Luce JM, et al (1990) Plasma tumor necrosis factor in patients with septic shock, Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141: 94–97PubMedGoogle Scholar
  8. 8.
    Roten R, Markert M, Feihl F, Schaller MD, Tagan MC, Perret CI (1991) Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am Rev Dis 143: 590–592Google Scholar
  9. 9.
    Tran Van Hieu J, Misset B, Lebargy F, Carlet J, Bernaudin JF (1993) Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome. Am Rev Respir Dis 147: 1585–1589Google Scholar
  10. 10.
    Jacobs RF, Tabor DR, Burks AW, Campbell GD (1989) Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis 140: 1686–1692PubMedCrossRefGoogle Scholar
  11. 11.
    Donnelly SC, Strieter RM, Kunkel SL, et al (1993) Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341: 643–647PubMedCrossRefGoogle Scholar
  12. 12.
    Miller EJ, Cohen AB, Nagao S, et al (1992) Elevated levels of NAP-1/Interleukin-8 are present in the airspaces of patients with ARDS and are associated with increased mortality. Am Rev Respir Dis 146: 427 -432PubMedGoogle Scholar
  13. 13.
    Strieter RM, Zhank K, Phan SH, Standiford TJ, Lukacs NW, Kunkel SL (1995) A role for C-C chemokines in fibrotic lung disease. L Leukoc Bioi 57: 782–787Google Scholar
  14. 14.
    Xing Z, Jordana M, Kirpalani H, Driscoll KE, Schall TJ, Gauldie J (1994) Cytokine expression by neutrophils and macrophages in vivo: Endotoxin induces tumor necrosis factor-α, macrophage inflammatory protein 2, IL-1β, and IL-6 but not RANTES or TGFβ1 mRNA expression in acute lung inflammation. Am J Respir Cell Mol Biol 10: 148–153PubMedGoogle Scholar
  15. 15.
    Chantry D, Turner M, Abney E, Feldmann M (1989) Modulation of cytokine production by transforming growth factor-β. J Immunol 142: 4295–4300PubMedGoogle Scholar
  16. 16.
    Ulich TR, Yin S, Guo K, Yi ES, Remick D, Del Castillo J (1991) Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor-β inhibit acute inflammation. Am J Pathol 138: 1097–1101PubMedGoogle Scholar
  17. 17.
    Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA (1993) Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 151: 5666–5674PubMedGoogle Scholar
  18. 18.
    De Waal Malefyt R, Figdor CG, Huijbens R, et al (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 151: 6370–6381Google Scholar
  19. 19.
    Dayer JM, Isler P, Nicod LP (1993) Adhesion molecules and cytokine production. Am Rev Respir Dis 148 (Suppl): S70–S74PubMedGoogle Scholar
  20. 20.
    Gadaleta D, Davis JM (1994) Pulmonary failure and the production of leukotrienes. J Am Coll Surg 178: 309–319PubMedGoogle Scholar
  21. 21.
    Henson PM, Barnes PI, Banks-Schlegel SP (1992) Platelet-activation factor: Role in pulmonary injury and dysfunction and blood abnormalities (NHLB Workshop Summary). Am Rev Respir Dis 145: 726–731PubMedGoogle Scholar
  22. 22.
    Rabinovici R, Bugelski PI, Esser KM, Hillegass LM, Vernick J, Feuerstein G (1993) ARDS-like lung injury produced by endotoxin in platelet activating factor-prim at rats. J Appl Physiol 74: 1791–1802PubMedGoogle Scholar
  23. 23.
    Matsumoto K, Taki F, Kondoh Y, Taniguchi H, Takagi K (1992) Platelet activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clin Exp Pharmacol Physiol 19: 509–515PubMedCrossRefGoogle Scholar
  24. 24.
    Hocking DC, Phillips PG, Ferro TJ, Johnson A (1990) Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha. Circulation Research 67: 68–77PubMedGoogle Scholar
  25. 25.
    Smith CS, Parker L, Shearer WT (1994) Cytokine regulation by platelet activating factor in a human B cell line. J Immunol (USA) 153: 3997–4005Google Scholar
  26. 26.
    Hill ME, Bird IN, Daniels RH, Elmore MA, Finnen MJ (1994) Endothelial cell-associated platelet activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1b-treated endothelial monolayers. J Immunol (USA) 153: 3673–3683Google Scholar
  27. 27.
    Moya FR, Hoffman DR, Zhao B, Johnston JM (1993) Platelet activating factor in surfactant preparations. Lancet 341: 858–860PubMedCrossRefGoogle Scholar
  28. 28.
    Imai Y, Kawano T, Miyasaka K, Takata M, Imai T, Okuyama K (1994) Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 150: 1550–1554PubMedGoogle Scholar
  29. 29.
    Campbell EJ, Senior RM, Welgus HG (1987) Extracellular matrix injury during lung inflammation. Chest 92: 161–167PubMedCrossRefGoogle Scholar
  30. 30.
    Woessner JF Jr (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145–2154PubMedGoogle Scholar
  31. 31.
    Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer JM. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome (ARDS). (Unpublished observations)Google Scholar
  32. 32.
    Clark JG, Milberg JA, Steinberg KP, Hudson LD (1995) Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 122: 17–23PubMedGoogle Scholar
  33. 33.
    Lacraz S, Nicod L, Galve-de Rochemonteix B, Baumberger Ch, Dayer JM, We1gus HG (1992) Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 90: 383–388CrossRefGoogle Scholar
  34. 34.
    Lotz M, Guerne PA (1991) Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-l/EPA). J BioI Chern 266: 2017–2020Google Scholar
  35. 35.
    Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG (1991) Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J Immunol 146: 2724–2729PubMedGoogle Scholar
  36. 36.
    Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG (1990) Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-γ. J Clin Invest 86: 1204–1210PubMedCrossRefGoogle Scholar
  37. 37.
    Tai Y, Bazan HE, Bazan NG (1995) Platelet activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium. Invest Ophtalmol Vis Sci 36: 345–354Google Scholar
  38. 38.
    Jochum M, Gippner-Steppert C, Machleidt W, Fritz H (1994) The role of phagocyte proteinases and proteinase inhibitors in multiple organ failure. Am J Respir Crit Care Med 150: S123–S130PubMedGoogle Scholar
  39. 39.
    Heffner JE, Repine JE (1989) Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 140: 531–554PubMedCrossRefGoogle Scholar
  40. 40.
    Cochrane CG, Spragg R, Revak SD (1993) Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 71: 754–761CrossRefGoogle Scholar
  41. 41.
    Pacht ER, Timerman AP, Lykens MG, Merola AJ (1991) Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100: 1397–1403PubMedCrossRefGoogle Scholar
  42. 42.
    Bunnell E, Pacht ER (1993) Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 148: 1174–1178PubMedGoogle Scholar
  43. 43.
    Ishii Y, Partridge CA, Del Vecchio PJ, Malik AB (1992) Tumor necrosis factor-amediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. J Clin Invest 89: 794–802PubMedCrossRefGoogle Scholar
  44. 44.
    Warner BB, Burhans MS, Clark JC, Wispé JR (1991) Tumor necrosis factor-α increases Mn-SOD expression: Protection against oxidant injury. Am J Physiol 260: L296–L301PubMedGoogle Scholar
  45. 45.
    Piedboeuf B, Johnston CJ, Watkins RH, et al (1994) Increased expression of tissue inhibitor of metalloproteinases (TIMP-I) and metallothionine in murine lungs after hyperoxie exposure. Am J Respir Cell Mol Biol 10: 123–132PubMedGoogle Scholar
  46. 46.
    Zapol WM, Jones R (1987) Vascular components of ARDS. Clinical pulmonary hemodynamics and morphology. Am Rev Respir Dis 136: 471–474PubMedCrossRefGoogle Scholar
  47. 47.
    Fuchs-Buder T, De Moerloose Ph, Ricou B, et al (1996) Time course of procoagulant activity and d-dimer in bronchoalveolar fluid of patients at risk for or with ARDS. Am J Respir Crit Care Med (In press)Google Scholar
  48. 48.
    Idell S, James KK, Levin EG, et al (1989) Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 84: 695–705PubMedCrossRefGoogle Scholar
  49. 49.
    Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ (1992) The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 667: 1–12PubMedCrossRefGoogle Scholar
  50. 50.
    Pison U, Max M, Neuendank A, Weissbach S, Pietschmann S (1994) Host defence capacities of pulmonary surfactant: Evidence for non-surfactant functions of the surfactant system. Eur J Clin Invest 24: 586–599PubMedCrossRefGoogle Scholar
  51. 51.
    Kremlev SG, Phelps DS (1994) Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol 267: L712–L719PubMedGoogle Scholar
  52. 52.
    Wright JR, Youmans DC (1993) Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol 264: L338–L344PubMedGoogle Scholar
  53. 53.
    Wispe JR, Clark JC, Warner BB, et al (1990) Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein. J Clin Invest 86: 1954–1960PubMedCrossRefGoogle Scholar
  54. 54.
    Ariaz-Diaz J, Vara E, Garcia C, Balibrea JL (1994) Tumor necrosis factor-α-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins. J Clin Invest 94: 244–250CrossRefGoogle Scholar
  55. 55.
    Fischer CJ, Slotman GJ, Opal AM, et al and the IL-1RA sepsis syndrome study group (1994) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 22: 12–21CrossRefGoogle Scholar
  56. 56.
    Lewis-Molock Y, Suzuki K, Taniguchi N, Mguyen DH, Mason RJ, White CW (1994) Lung manganese superoxide dismutase increases during cytokine-mediated protection against pulmonary oxygen toxicity in rats. Am J Respir Cell Mol Biol 10: 133–141PubMedGoogle Scholar
  57. 57.
    Welsh CH, Lien D, Worthen GS, Weil JV (1988) Pentoxifylline decreases endotoxininduced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog. Am Rev Respir Dis 138: 1106–1114PubMedGoogle Scholar
  58. 58.
    Suter PM, Domenighetti G, Schaller MD, Laverrière MC, Ritz R, Perret Cl (1994) Nacetylcysteine enhances recovery from acute lung injury in man: A randomized, doubleblind, placebo-controlled clinical study. Chest 105: 190–194PubMedCrossRefGoogle Scholar
  59. 59.
    Reinhart K, Spies CD, Meier-Hellmann A, et al (1995) N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation. Am J Respir Crit Care Med 151: 773–779PubMedGoogle Scholar
  60. 60.
    Wheeler AP, Hardie WD, Bernard GR (1992) The role of cyclooxygenase products in lung injury induced by tumor necrosis factor in sheep. Am Rev Resp Dis 145: 632–639PubMedGoogle Scholar
  61. 61.
    Jenkins JK, Carey PD, Byrne K, Sugerman HJ, Fowler AA III (1991) Sepsis-induced lung injury and the effects of ibuprofen pretreatment. Am Rev Respir Dis 143: 155–161PubMedGoogle Scholar
  62. 62.
    Schutzer KM, Larsson A, Risberg B, Falk A (1994) Leukotriene receptor antagonism prevents lung protein leakage and hypoxaemia in a septic cat model. Eur Respir J 7: 1131–1137PubMedGoogle Scholar
  63. 63.
    Wollert PS, Menconi MJ, O’Sullivan BP, Wang H, Larkin V, Fink MP (1993) LY255283, a novelleukotriene B4 receptor antagonist, limits activation of neutrophils and prevents acute lung injury induced by endotoxin in pigs. Surgery 114: 191–198PubMedGoogle Scholar
  64. 64.
    Wasserman MA, Welton AF, Renzetti LM (1995) Synergism exhibited by LTDA and PAF receptor antagonists in decreasing antigen-induced airway microvascular leakage. Adv Prostaglandin Thromboxane Leukot Res (USA) 23: 271–273Google Scholar
  65. 65.
    Cochrane CG, Revak SD (1994) Protein-phospholipid interactions in pulmonary surfactant. Chest 195 (Suppl 3): 57S-62SGoogle Scholar
  66. 66.
    Vincent JS, Revak SD, Cochrane CD, Levin IW (1993) Interactions of model human pulmonary surfactants with a mixed phospholipid bilayer assembly: Raman spectroscopic studies. Biochemistry (USA) 32: 8228–8238CrossRefGoogle Scholar
  67. 67.
    Snell GI, Salamonsen RF, Bergin P, Esmore DS, Khan S, Williams TJ (1995) Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med 151: 1263–1266PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • B. Ricou

There are no affiliations available

Personalised recommendations